CSF2 and pulmonary alveolar proteinosis: In this section, we will discuss the applications of GM-CSF administration, rituximab, pharmacotherapies that restore lipid homeostasis in AMs, AM transplantation, and induced pluripotent stem cell (iPSC)-derived AMs in the treatment of PAP.